Lungs News and Research

RSS

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

An updated clinical practice guideline released last week by the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors recommends how to reduce the likelihood of blood clots after hip or knee replacement surgery, procedures that more than 800,000 Americans undergo each year. The new guideline suggests use of preventive treatments and advises against routinely screening patients after surgery using ultrasound imaging.

1 Oct 2011

ShurTech Brands to donate $100,000 to BCRF

According to the American Cancer Society, after lung cancer, breast cancer is the second leading cause of cancer death in women. So, for the third consecutive year, ShurTech Brands, LLC, marketers of the Duck brand of duct tapes, packaging supplies and home products, is joining the fight to find a cure by contributing up to $100,000 to The Breast Cancer Research Foundation.

1 Oct 2011

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

ADVENTRX Pharmaceuticals, Inc. announced today that it held a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the complete response letter (CRL) it received in August from the FDA regarding the Company's New Drug Application (NDA) for Exelbine (vinorelbine injectable emulsion) for the treatment of non-small cell lung cancer.

1 Oct 2011

Young woman fights tobacco within the Hispanic Community

Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not -- she took action to save the lives of her fellow students and community.

30 Sep 2011

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Researchers at the Moffitt Cancer Center in Tampa, Fla., and colleagues have found that tumor cell resistance to a specific cancer immunotherapy designed to kill cancer cells can be blamed on a mechanism that involves the production of a free radical peroxynitrite (PNT) that causes resistance to therapeutic cancer-killing cells.

30 Sep 2011

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

A drug recently approved by the U.S. Food and Drug Administration for treatment of an adult cancer targets a malfunctioning gene discovered more than a decade earlier at St. Jude Children's Research Hospital. The story highlights how scientific findings from St. Jude can be translated into therapies and tests that in addition to helping children, also help adults.

30 Sep 2011

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

Array BioPharma Inc. today announced results from a randomized Phase 2 placebo-controlled study conducted by AstraZeneca comparing the efficacy of selumetinib in combination with docetaxel with docetaxel alone in the second-line treatment of 87 patients prospectively selected with KRAS-mutant, locally advanced or metastatic non-small cell lung cancer.

30 Sep 2011

United Nations 66th General Assembly to discuss how to reduce NCDs

University of Bergen researchers have contributed to an international declaration on the prevention of non-communicable diseases. Now the UN is discussing the issue.

30 Sep 2011

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Circadian Technologies Limited (ASX: CIR, OTCQX:CKDXY) is extremely proud to announce that its 100% owned subsidiary, Vegenics Pty Ltd, has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate clinical studies of VGX-100. The first trial (Phase I) will involve the treatment of a variety of different cancer types in patients with late stage cancer.

29 Sep 2011

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

A pill from Bulgaria during the Soviet era shows promise for helping millions of smokers cheaply and safely kick the habit, the first big clinical trial of it shows. It is unclear whether it will ever reach the market in the U.S. or Western Europe though.

29 Sep 2011

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

Tobacco companies knew that cigarette smoke contained radioactive alpha particles for more than four decades and developed "deep and intimate" knowledge of these particles' cancer-causing potential, but they deliberately kept their findings from the public, according to a new study by UCLA researchers.

29 Sep 2011

Plausible way to circumvent drug resistance in breast cancer cells

Breast cancer cells that mutate to resist drug treatment survive by establishing tiny pumps on their surface that reject the drugs as they penetrate the cell membrane - making the cancer insensitive to chemotherapy drugs even after repeated use.

29 Sep 2011

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

Intensive control of blood sugar levels beyond standard targets provides no additional protection against cognitive decline in older people with diabetes than standard treatment, according to a national study coordinated by researchers at Wake Forest Baptist Medical Center.

29 Sep 2011

Study reports positive effect of RESPeRATE on CHF patients

InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange, today announced that European Journal of Heart Failure, a peer reviewed medical journal of the European Society of Cardiology, published the results of a 72-patients, randomized, controlled study which demonstrated that device-guided respiratory modulation with RESPeRATE applied at the home setting can significantly relieve symptoms of heart failure in elderly patients.

29 Sep 2011

Scientists warn about climate-induced increase in death rates over the next 60 years

Scientists are warning that death rates linked to climate change will increase in several European countries over the next 60 yrs.

28 Sep 2011

Emissions from livestock farms cause lung patients living nearby to experience more exacerbations

Emissions from livestock farms cause asthma and COPD patients living nearby to experience more exacerbations, according to research presented today at the European Respiratory Society's Annual Congress in Amsterdam.

28 Sep 2011

Postmenopausal HRT linked with increased risk of asthma hospitalisations in women

Women taking postmenopausal hormone replacement therapy (HRT) may have an increased risk of severe asthma attacks requiring hospitalisation, scientists warn.

28 Sep 2011

Asthmatic kids with type 1 diabetes have tougher time maintaining healthy sugar levels: Study

The reason why asthma might complicate pediatric diabetes care remains unclear, however, and is “something that needs to be explored more,” said Dr. Anita Swamy, a pediatric endocrinologist and medical director of the Chicago Children's Diabetes Center at La Rabida Children's Hospital in Chicago. She was not involved in the new study. The study appears in the October issue of Pediatrics.

27 Sep 2011

Raised blood pressure may higher risk of cancer, death

Raised blood pressure is linked to a higher risk of developing cancer or dying from the disease according to the findings of the largest study to date to investigate the association between the two conditions.

27 Sep 2011

Patients with chronic conditions likely to change their preferences for CPR

Patients with chronic conditions are likely to change their preferences for receiving emergency procedures in the event of cardiac arrest, according to new findings.

27 Sep 2011

Lungs News and Research

New AAOS guideline recommends how to reduce DVT, PE after joint replacement surgery

ShurTech Brands to donate $100,000 to BCRF

ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA

Young woman fights tobacco within the Hispanic Community

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

ALK gene discovered by St. Jude scientists associated with FDA approved adult cancer drug

Array announces results from selumetinib Phase 2 combination study on KRAS-mutant NSCLC

United Nations 66th General Assembly to discuss how to reduce NCDs

Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors

Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation

Tobacco companies deliberately kept findings of cancer-causing radioactive particles from the public

Plausible way to circumvent drug resistance in breast cancer cells

Intensive blood glucose control therapy provides no added benefit against cognitive decline in older diabetics

Study reports positive effect of RESPeRATE on CHF patients

Scientists warn about climate-induced increase in death rates over the next 60 years

Emissions from livestock farms cause lung patients living nearby to experience more exacerbations

Postmenopausal HRT linked with increased risk of asthma hospitalisations in women

Asthmatic kids with type 1 diabetes have tougher time maintaining healthy sugar levels: Study

Raised blood pressure may higher risk of cancer, death

Patients with chronic conditions likely to change their preferences for CPR

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News